**LITH** the Time is Now

Get it on your screen NOW Good Morning All, Our newest alert could be one ready for some dramatic moves! Hurry and add LITH to your watch list. According to Yahoo Finance, LITH has a tiny float of just 3.5M shares. This is TINY! A float is an important number to look at because it indicates how many shares are actually available to be bought and sold by the general investing public. With only a few million shares for a float, it doesn't look like LITH has that much supply. Think of supply and demand. If demand rises with a limited supply, what happens to the price? It goes up. This is just one reason to keep your eyes on LITH and watch for any sudden moves. You never know when the stock could be gearing up for a breakout! Earlier this month shares were as low as 26 cents and they hit as high as 62 cents last week! With Wall Street continuing to learn about the company's new developments, this could be the best time to be paying attention... LITH recently announced that it has entered the CBD industry though a strategic asset acquisition. How recent is this news? It's only DAYS old! CBD has become three very hot letters in recent years. The collective market for CBD sales is expected to exceed $20 billion in the United States by 2024, according to BDS Analytics and ArcView Market Research. The tsunami of CBD-infused products has hit so suddenly, and with such force that its making almost everyone pay attention! Even Martha Stewart has a CBD business! Why is CBD so popular? CBD is said to help ease anxiety and inflammation as well as an assortment of other issues. It doesn't get people high because it doesn't contain THC, the psychoactive component of the cannabis plant. This means many people can use it, including children. CBD is also said to be a possible solution for the ongoing opioid crisis. ] The opioid crisis cost $696 billion in 2018 and more than $2.5 trillion between 2015 and 2018, according to an estimate by the White House Council of Economic Advisers. Trillions of dollars in just three years! LITH could see plenty of upside ahead as more learn about the company's news. Hurry and start your due diligence! You can begin by reading our exclusive report on the company: U.S. Lithium Corporation (OTC: LITH) U.S. Lithium Corporation (OTC: LITH) was formerly an exploration and development company focused in North America on lithium and related resources for the rapidly growing energy storage industry.  Keep in mind that the company is planning to change its name AND ticker! Effective January 20, 2020, LITH has acquired four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock.  As a result of these acquisitions the Company will change its primary business from minerals to cannabinoids.  The Company also intends to change its name, stock symbol and website within the next 30 days to better reflect this new strategic direction. Keep your eyes peeled for this! “Our Board is committed to maximize shareholder value and, in this light, we have identified accretive acquisition opportunities that would potentially position our company in a high growth industry while also helping improve the lives of individuals,” stated Gregory Rotelli, LITH's Chairman of the Board. The collective market for CBD sales is expected to exceed $20 billion in the United States by 2024, according to BDS Analytics and ArcView Market Research. CBD is in a unique position compared to other nutraceutical or supplement ingredients for two reasons: 1) as an active ingredient in cannabis, it has a documented history of health and wellness use, and anecdotal evidence of efficacy, and 2) it is one of the few natural remedies with scientific basis for at least some of the claims being made about its curative powers.  Unsurprisingly, consumers are fascinated by the perceived benefits of CBD and sales are steadily increasing. Through its acquisition LITH now has contractual relationships with well-known farmers for raw material acquisition, certified contract manufacturers for production, and distribution partners to sell exceptional products at the lowest possible cost to both the CBD and medical industry.  The Company will control its products from ’seed to shelf’ without the need for expensive infrastructure and operating overhead. Instead, LITH will be able to dedicate its resources primarily to product development and sales. “This acquisition positions our company as a contract manufacturer and supplier in the high growth cannabinoid industry. Going forward our focus will be on helping improve the lives of individuals while maximizing shareholder value,” stated Mr. Rotelli, Chairman of the Board. LITH now has the key farming, manufacturing, and distribution agreements in place to become a major force in this exciting new growth industry! Announcements regarding initial products and distribution channels will be forthcoming over the coming weeks so watch for developments. The CBD industry is a big-money business. In 2014 legal global sales were approximately $3.4 billion. By 2018 that number was up to $11 billion.  New York-based investment bank Cowen & Co. released a study on the CBD (cannabidiol) market and found that nearly 7 percent of the 2,500 polled, said they had used CBD. CBD is now one of the top keywords searched on Google. In April 2019, the last month data were collected, there were 6.4 million CBD Google searches, and searches increased 160.4% in 2018 compared to 2017, according to research published in the peer-reviewed JAMA Network Open. Check out some of these CBD Facts:     Using cannabidiol will not get you high.     Hemp-derived CBD is legal in all 50 states.     Over a quarter of the US population has tried CBD.     CBD can substantially reduce pain levels.     Medical cannabis can be substituted for opioids. The Council of Economic Advisers (CEA) estimates the opioid crisis cost $696 billion in 2018—or 3.4 percent of GDP—and more than $2.5 trillion for the four-year period from 2015 to 2018.  It may be a matter of time that CBD will become a staple in a household the way aspirin is. Especially with all of the studies done on his benefits. Several studies have highlighted specific medical opportunities for CBD: A study in the European Journal of Pain, for one, showed that topical CBD helped lower arthritis-related pain and inflammation. In another recent study published in the journal Pain, Dr. Gabriella Gobbi and colleagues suggested that low-dose CBD was effective at reducing pain and anxiety by interfering with a neurotransmitter linked to both [( A study authored by physicians from the New York University Medical School and published in the Neurotherapeutics journal 10.1007/s13311-015-0387-1 determined that existing preclinical evidence strongly supports CBD as a treatment for generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive–compulsive disorder, and post-traumatic stress disorder when administered acutely. The Hadassah Hebrew University Hospital published a study in Neuropharmacology Volume 54 Issue 1 on the possible use of CBD as a therapeutic agent for the treatment of Type 1 diabetes: [( PLOS One published a study: [ [id=10.1371/journal.pone.0018440]( CBD treatment for fibromyalgia produced very promising results for future uses in treatment, due to a great reduction in symptoms in the participants that used CBD. In a study published in the Journal of Clinical Investigation, J Clin Invest. 2014;124(9):3713-3724. [( the National Institute of Health discovered that CBD, due to the combined lipostatic, antiproliferative, and anti-inflammatory effects, has potential as a promising therapeutic agent for the treatment of acne vulgaris, the most common human skin disease affecting the quality of life for millions worldwide. “We look forward to expanding the usage of CBD and other Cannabinoids for specific medical purposes to benefit people. We have already spoken to key third-party laboratories, clinical research groups, and medical facilities about partnering with us to help implement our plans” said LITH's Chairman Mr. Rotelli. CBD has become a major craze and this is one reason why we are super excited about LITHright now. With a tiny float, and very exciting news this month, LITHmay be on its way to a major breakout. U.S. Lithium Corporation (OTC: LITH) could be the next CBD play on Wall Street to shine! Sources: [( [ [( [( [( [(   To get plays EARLY make sure you grab your cellphone (which you are probably doing right now) and join our VIP text messaging list (standard text and messaging rates may apply)to make it even easier, if you are on your cell phone now click this Button Below:  [SIGN ME UP NOW]( Also PLEASE take the time to read the following:   ( I DO NOT MAKE ANY RECOMMENDATIONS TO BUY OR SELL ANY STOCKS, I JUST PROFILE COMPANIES AND YOU DECIDE WHAT TO DO)   Here are some of my unlicensed, amateur and biased opinions:   Placing a Trade    First and foremost, you should always have streaming Level II quotes when trading. I honestly do not know how anyone trades without it! When trading, please follow the below guidelines:    Always use a Limit Order:    Most brokers won’t even allow you to use Market Orders. Limit Orders allow you to set the price that you want to buy and sell the stock at. This is common knowledge however, you may see some novice traders make the mistake of placing a market order to sell and take out all buyers at the bid, effectively overselling the stock to lower prices.    Buy and Sell at the Ask:    Many don’t realize that when you buy at the Ask price, you are HELPING the stock price to move up! Once that offer is gone from the shares you purchased, Market Makers could move up to the next offer price as they will see there are buyers at the current price. If you decide to place an order at the bid, you are basically hoping someone will sell their shares to you at this price and you may never get filled and miss the action. It is not always a bad idea to bid sit, as you are creating “bid support”, if you believe the price may come down again and you are not willing to buy higher.    Using Stop Limit Orders:    Some brokers do not allow you to use stops, however, if you can – it is always a good idea to set your stop loss at the lowest price you are willing to take a loss. You may kick yourself when the stock moves back up and your stop already executed, but remember, there will always be other opportunities and its always best to cut your losses just in case.    All or None Orders (Fill or Kill):    An example of an all or none order is when someone places an order to buy 100,000 shares @ .01 as an “all or none limit” order. By doing this they are telling the market that they wish to be filled on their entire position at .01 or not to be filled at all. For some reason we have seen market makers ignore these sort of orders on many occasions especially when a stock is on the move. We suggest against it but you will ultimately make the decision.    Do Not Chase (ONE OF THE MOST IMPORTANT):    Many people want to buy a stock so badly that they end up chasing the stock as it goes up. When they finally fill their order, they may have purchased it too high as traders who bought shares earlier begin to take profit, effectively lowering the stock price and making you a bag holder. Remember, 90% of the time, a stock will always retrace/dip back to an attractive level for you to grab shares.    Stock Gaps:    If a stock gaps up too high in pre-market, do Not Chase It. A big gap is typically 20-50% or more pre- market or within the first 5-10 minutes of the market opening. Most stocks that gap up will come down again during the day depending on what created the catalyst. Buying is always the catalyst but every once in a while there is earth shattering news on some of these small caps that makes pullbacks unlikely in the short term. Most of the time, when a stock gaps up the market makers will attempt to push it lower starting at this time to try to get investors to panic and sell shares back to them so they can make a profit on any shares they are short from filling orders on the gap. If you like the stock and it gaps up you can usually pick up cheaper shares when and if the market settles back.    Sell Into Strength Not Weakness:    Once you have taken a position in a stock you need to decide the price you would like to sell your shares. Most would recommend that you put a GTC sell order at that price. Unfortunately as traders have learned to utilize level 2, its best not to do submit GTC sell orders due to the possibility that your order will be represented by a market maker and it will seem as if there is resistance at that level which may compel sellers to get out of their position at a price lower than your price. We suggest that you watch the stock closely and once it hits your price target you can submit your order to sell. It’s important to understand that it’s always best to liquidate the stock into strength and preferably in smaller increments if you have a big position.    There you have it!! These are ALL my biased, amateur and unlicensed opinions, should YOU choose freely, knowingly and intelligently to Play ANY of my featured play's!!   (Please READ my statement below as well, it will help you understand how I benefit from this newsletter)   Also always remember that every single alert I send is very volatile and risky. Any one of them could turn into a big loser. In my personal opinion, no matter how much potential any company has, 99% of the time all that matters is HOW THE STOCK TRADES. If a stock doesn’t trade well, nothing else matters. Don’t believe the hype. Be sure to use a tight stop, book profits quickly on these volatile trades, never let any one trade move too far against you, watch out for gaps, make sure the stock is trading in a healthy way before you enter, and monitor it closely to make sure momentum is positive. It’s always safest to book profits quickly, even on alerts with long-term potential. (Amateur biased unlicensed opinions)   I would like to also explain how my Newsletter Makes MONEY!!   I DON’T FRON TLOAD, BUY, RECEIVE any SHARES of a Company I Profile!! I NEVER OWN ANY POSITION IN A COMPANY I ALERT/PROFILE!! It would be UNFAIR, WRONG and ILLEGAL for me to have a position in ANY Company I ever Profile on my Newsletter! I am what is known as a STOCK PROMOTER!!   I just wanted to address this issue for some people who might think I trade the companies I profile on my Newsletter or I own a position before or during the time I profile them!!! The honest truth is I DO NOT!!….. I do get CASH compensation to profile companies most of the times I talk about them in my Newsletter, this is HOW I MAKE MONEY and pretty much how 99% of ALL the other Newsletters out there make money…… Most of you have signed up to my Newsletter because of an advertisement you saw, well it costs money to run those advertisements…. I ALWAYS Disclose how much and who paid me in my Disclaimer at the end of each e-mail!!!   Here is some information directly from the SEC Website: [(   Tips for Checking Out Newsletters   “Find out whether the newsletter received payment to “tout” or recommend the stock and, if so, what it received and from whom.   Because the U.S. Constitution’s First Amendment protects freedom of speech, the SEC cannot simply prohibit newsletters from recommending or touting particular stocks. But when newsletters receive payment for touting, the securities laws require them to disclose specifically who paid them, the amount, and the type of payment (cash, stock, or some other thing of value).   Read carefully what the newsletter says about payments it receives.   Be suspicious of newsletters that do not specifically disclose these items: who paid them, the amount, and the type of payment. The following examples raise red flags because they do not contain specific information:   “From time to time, XYZ Newsletter may receive compensation from companies we write about.”   “From time to time, XYZ Newsletter or its officers, directors, or staff may hold stock in some of the companies we write about.”   “XYZ Newsletter receives fees from the companies we write about in our newsletter.”   Think twice about newsletters that bury their disclosures or put them in tiny, hard-to-read typeface. Legitimate online newsletters that have been paid to tout stocks will clearly and specifically tell investors who paid them, the amount, and the type of payment. Look for their disclosure statements in articles about particular companies or in a list or chart on their websites.”   I hope this answers a lot of your questions and also gives you a better perspective to my play’s the Next Time you see one!! Don’t forget to tell everyone you know about [PTE.la]( help my Newsletter Grow!!   Remember to trade smart, research your options, and use due diligence!                 © 2019 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC has been compensated Two-Thousand Five-Hundred Dollars Cash via bank wire transfer by a third party for a 1 Day Marketing Program regarding LITH. Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website.  ProTrader Elite LLC | 9 Downing Street, Newark, NJ 07105 [Unsubscribe {EMAIL}]( [About Constant Contact]( Sent by customerservice@protraderelite.com in collaboration with [Trusted Email from Constant Contact - Try it FREE today.]( [Try email marketing for free today!](